The Health Ministry’s decision to raise the prices of some medications last year failed to prevent future shortages of key meds, Mohamed Mostafa writes for Al Borsa. The ministry had promised that it would allow another wave of price increases later in the year to encourage manufacturers to stick it out and continue producing. Since the second phase never came, pharma companies are incurring losses, while citizens have consistently been told that certain medications are in short supply or completely missing from the market.
More from Enterprise
AI in Egyptian banking is “in its infancy,” and the pause is deliberate
Bankers say the rules aren’t written yet. Data center builders…
Banks threaten to look beyond London as windfall tax talk grows
International lenders say more tax could tip the balance as…
EFG has three more IPOs lined up before year-end, including one hefty offering
Group CEO Karim Awad credits the central bank’s decision to…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…